1. Home
  2. PESI vs ENLV Comparison

PESI vs ENLV Comparison

Compare PESI & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perma-Fix Environmental Services Inc.

PESI

Perma-Fix Environmental Services Inc.

HOLD

Current Price

$9.81

Market Cap

208.1M

Sector

Industrials

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$0.86

Market Cap

196.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PESI
ENLV
Founded
1990
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.1M
196.2M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
PESI
ENLV
Price
$9.81
$0.86
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$20.00
AVG Volume (30 Days)
282.6K
344.9K
Earning Date
05-08-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
43.61
N/A
EPS
N/A
N/A
Revenue
$642,000.00
N/A
Revenue This Year
$34.62
N/A
Revenue Next Year
$77.02
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.14
$0.66
52 Week High
$16.50
$2.10

Technical Indicators

Market Signals
Indicator
PESI
ENLV
Relative Strength Index (RSI) 44.25 59.70
Support Level $9.82 $0.77
Resistance Level $12.33 $1.23
Average True Range (ATR) 0.68 0.05
MACD 0.09 0.02
Stochastic Oscillator 54.12 99.41

Price Performance

Historical Comparison
PESI
ENLV

About PESI Perma-Fix Environmental Services Inc.

Perma-Fix Environmental Services Inc is a nuclear services company and provider of nuclear and mixed waste management services. The company's nuclear waste services include treatment and management of radioactive and mixed waste (waste containing both hazardous and low-level radioactive waste). The company operates through two segments: i) The treatment segment: It offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and ii) the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: